Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Cisplatin Cytotoxicity: DNA and Plasma Membrane Targets

Author(s): Amelie Rebillard, Dominique Lagadic-Gossmann and Marie-Therese Dimanche-Boitrel

Volume 15 , Issue 26 , 2008

Page: [2656 - 2663] Pages: 8

DOI: 10.2174/092986708786242903

Price: $65

Abstract

Most current anticancer therapies induce tumor cell death through apoptosis where its specific involved pathways are poorly understood. For example, for many DNA-damaging agents, the specific biochemical lesions (DNA adducts) are associated with the induction of apoptosis via the mitochondria death pathway. However, several of these DNA-damaging agents like cisplatin induce apoptosis through plasma membrane disruption, triggering the Fas death receptor pathway. In this review, we focus on the role of early plasma membrane events in cisplatin-induced apoptosis. Special attention is given to changes in plasma membrane fluidity, inhibition of NHE1 exchanger, activation of acid sphingomyelinase and their consequences on the Fas death pathway in response to cisplatin.

Keywords: membrane fluidity, membrane lipid rafts, acid sphingomyelinase, Fas death receptor, Na+/H+ exchanger 1 (NHE1), DNA adducts


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy